Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.28B
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
4.17M
-
Shares change
-
-3.36M
-
Total reported value, excl. options
-
$343M
-
Value change
-
-$277M
-
Number of buys
-
11
-
Number of sells
-
-13
-
Price
-
$82.38
Significant Holders of Medtronic plc - Common Stock (MDT) as of Q4 2023
29 filings reported holding MDT - Medtronic plc - Common Stock as of Q4 2023.
Medtronic plc - Common Stock (MDT) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.17M shares
of 1.28B outstanding shares and own 0.32% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (127M shares), BlackRock Inc. (119M shares), STATE STREET CORP (60.9M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (28.9M shares), Capital Research Global Investors (28.8M shares), GEODE CAPITAL MANAGEMENT, LLC (26.7M shares), JPMORGAN CHASE & CO (25.4M shares), WELLINGTON MANAGEMENT GROUP LLP (24M shares), MORGAN STANLEY (23.3M shares), and BANK OF AMERICA CORP /DE/ (22.6M shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.